NCT04872075View on ClinicalTrials.gov

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event

NACompletedINTERVENTIONAL
Enrollment

6,678

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

June 13, 2021

Study Completion Date

June 13, 2021

Conditions
Covid19
Interventions
OTHER

Concert

People attending a concert in a closed area, with a mask

DIAGNOSTIC_TEST

Rapid nasopharyngeal antigen test for Sars-Cov-2

A nasopharyngeal swab at inclusion (up to 3 days before concert) to confirm eligibility

DIAGNOSTIC_TEST

Saliva Sample

Saliva samples sent by participant at Day0 and Day7

Trial Locations (1)

75012

AccorHotels Arena, Paris

All Listed Sponsors
collaborator

PRODISS

UNKNOWN

collaborator

WEEZEVENT

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER